Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/association-between-early-low-dose-hydrocortisone-therapy-in-extremely-XJI1j4w7Eg
References (41)
-
K. Watterberg (2004)
Adrenocortical function and dysfunction in the fetus and neonate.Seminars in neonatology : SN, 9 1
-
K. Rademaker, W. Vries (2009)
Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart.Seminars in fetal & neonatal medicine, 14 3
-
K. Watterberg, J. Gerdes, C. Cole, S. Aucott, E. Thilo, M. Mammel, R. Couser, J. Garland, H. Rozycki, C. Leach, C. Backstrom, M. Shaffer (2004)
Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter TrialPediatrics, 114
-
W. Frankenburg, J. Dodds, Philip Archer, H. Shapiro, Beverly Bresnick (1992)
The Denver II: a major revision and restandardization of the Denver Developmental Screening Test.Pediatrics, 89 1
-
D. Bassler, R. Plavka, E. Shinwell, M. Hallman, P. Jarreau, V. Carnielli, J. Anker, C. Meisner, C. Engel, M. Schwab, H. Halliday, C. Poets (2015)
Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.The New England journal of medicine, 373 16
-
L. Doyle, R. Ehrenkranz, H. Halliday (2014)
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.The Cochrane database of systematic reviews, 5
-
M. Charkaluk, P. Truffert, A. Fily, P. Ancel, V. Pierrat (2010)
Neurodevelopment of children born very preterm and free of severe disabilities: the Nord‐Pas de Calais Epipage cohort studyActa Pædiatrica, 99
-
G. Natalucci, B. Latal, B. Koller, C. Rüegger, Beate Sick, L. Held, H. Bucher, J. Fauchère (2016)
Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.JAMA, 315 19
-
J. Gosselin, S. Gahagan, C. Amiel‐Tison (2005)
The Amiel-Tison Neurological Assessment at Term: conceptual and methodological continuity in the course of follow-up.Mental retardation and developmental disabilities research reviews, 11 1
-
Odette Brunet, I. Lézine, H. Wallon (1952)
Le développement psychologique de la première enfance : présentation d'une échelle française pour examen des tout petitsPopulation, 7
-
Estella Janz-Robinson, N. Badawi, K. Walker, B. Bajuk, M. Abdel-latif (2015)
Neurodevelopmental Outcomes of Premature Infants Treated for Patent Ductus Arteriosus: A Population-Based Cohort Study.The Journal of pediatrics, 167 5
-
K. Kersbergen, L. Vries, B. Kooij, I. Išgum, K. Rademaker, F. Bel, P. Hüppi, J. Dubois, F. Groenendaal, M. Benders (2013)
Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants.The Journal of pediatrics, 163 3
-
F. Bonsante, G. Latorre, S. Iacobelli, V. Forziati, N. Laforgia, L. Esposito, A. Mautone (2006)
Early Low-Dose Hydrocortisone in Very Preterm Infants: A Randomized, Placebo-Controlled TrialNeonatology, 91
-
PY Ancel, F Goffinet, P Kuhn (2015)
Survival and morbidity of preterm children born at 22 through 34 weeks? gestation in France in 2011: results of the EPIPAGE-2 cohort study [published correction appears in JAMA Pediatr. 2015;169(4):323], 169
-
V. Heine, D. Rowitch (2009)
Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11betaHSD2-dependent mechanism.The Journal of clinical investigation, 119 2
-
C. Wright, H. Kirpalani (2011)
Targeting Inflammation to Prevent Bronchopulmonary Dysplasia: Can New Insights Be Translated Into Therapies?Pediatrics, 128
-
D. Josse (1997)
Echelle de développement psychomoteur de la première enfance Brunet-Lézine -
O. Peltoniemi, A. Lano, A. Yliherva, M. Kari, M. Hallman (2016)
Randomised trial of early neonatal hydrocortisone demonstrates potential undesired effects on neurodevelopment at preschool ageActa Paediatrica, 105
-
A. Jefferies (2012)
Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.Paediatrics & child health, 17 10
-
S. Kallapur, A. Jobe (2006)
Contribution of inflammation to lung injury and developmentArchives of Disease in Childhood - Fetal and Neonatal Edition, 91
-
I. Lézine (1958)
Le développement psychomoteur des jeunes prématurés., 7
-
O. Baud, L. Maury, F. Lebail, D. Ramful, Fatima Moussawi, C. Nicaise, V. Zupan-Simunek, A. Coursol, A. Beuchée, P. Bolot, P. Andrini, D. Mohamed, C. Alberti (2016)
Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trialThe Lancet, 387
-
Vasilis Moisiadis, S. Matthews (2014)
Glucocorticoids and fetal programming part 2: mechanismsNature Reviews Endocrinology, 10
-
M. Charkaluk, P. Truffert, P. Truffert, L. Marchand-martin, S. Mur, Monique Kaminski, P. Ancel, V. Pierrat (2011)
Very preterm children free of disability or delay at age 2: predictors of schooling at age 8: a population-based longitudinal study.Early human development, 87 4
-
D. Grier, H. Halliday (2003)
Corticosteroids in the prevention and management of bronchopulmonary dysplasia.Seminars in neonatology : SN, 8 1
-
I. Deary, W. Johnson (2010)
Intelligence and education: causal perceptions drive analytic processes and therefore conclusions.International journal of epidemiology, 39 5
-
P. Ancel, F. Goffinet, P. Kuhn, B. Langer, J. Matis, X. Hernandorena, P. Chabanier, L. Joly-Pédespan, B. Lecomte, F. Vendittelli, M. Dreyfus, B. Guillois, A. Burguet, P. Sagot, J. Sizun, A. Beuchée, F. Rouget, Amélie Favreau, E. Saliba, N. Bednarek, P. Morville, G. Thiriez, L. Marpeau, S. Marret, G. Kayem, X. Durrmeyer, M. Granier, O. Baud, P. Jarreau, D. Mitanchez, P. Boileau, P. Boulot, G. Cambonie, H. Daudé, A. Bédu, F. Mons, J. Fresson, R. Vieux, Corine Alberge, C. Arnaud, C. Vayssière, P. Truffert, V. Pierrat, D. Subtil, C. D’ercole, C. Gire, U. Simeoni, A. Bongain, L. Sentilhes, J. Rozé, J. Gondry, A. Léké, M. Deiber, O. Claris, J. Picaud, A. Ego, T. Debillon, Anne Poulichet, Eliane Coliné, A. Favre, O. Flechelles, S. Sampériz, D. Ramful, B. Branger, V. Benhammou, L. Foix‐L'Hélias, L. Marchand-martin, M. Kaminski (2015)
Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study.JAMA pediatrics, 169 3
-
O. Peltoniemi, M. Kari, K. Heinonen, T. Saarela, K. Nikolajev, S. Andersson, R. Voutilainen, M. Hallman (2005)
Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.The Journal of pediatrics, 146 5
-
B. Schmidt, R. Roberts, P. Davis, L. Doyle, K. Barrington, A. Ohlsson, A. Solimano, W. Tin (2007)
Long-term effects of caffeine therapy for apnea of prematurity.The New England journal of medicine, 357 19
-
M. Bax, M. Goldstein, P. Rosenbaum, A. Leviton, N. Paneth, B. Dan, B. Jacobsson, D. Damiano (2005)
Proposed definition and classification of cerebral palsy, April 2005.Developmental medicine and child neurology, 47 8
-
L. Doyle, R. Ehrenkranz, H. Halliday (2010)
Dexamethasone Treatment in the First Week of Life for Preventing Bronchopulmonary Dysplasia in Preterm Infants: A Systematic ReviewNeonatology, 98
-
K. Watterberg, M. Shaffer, Mary Mishefske, C. Leach, M. Mammel, R. Couser, S. Abbasi, C. Cole, S. Aucott, E. Thilo, H. Rozycki, C. Lacy (2007)
Growth and Neurodevelopmental Outcomes After Early Low-Dose Hydrocortisone Treatment in Extremely Low Birth Weight InfantsPediatrics, 120
-
B. Yoder, M. Harrison, R. Clark (2009)
Time-Related Changes in Steroid Use and Bronchopulmonary Dysplasia in Preterm InfantsPediatrics, 124
-
H. Hagberg, C. Mallard, D. Ferriero, S. Vannucci, S. Levison, Z. Vexler, P. Gressens (2015)
The role of inflammation in perinatal brain injuryNature Reviews Neurology, 11
-
O. Peltoniemi, A. Lano, R. Puosi, A. Yliherva, F. Bonsante, M. Kari, M. Hallman (2008)
Trial of Early Neonatal Hydrocortisone: Two-Year Follow-UpNeonatology, 95
-
EA Sand, C Emery-Hauzeur (1962)
The psychomotor development of the child during the first 2 years (Brunet-Lezine test) [in French], 62
-
A. Jobe (2011)
The new bronchopulmonary dysplasiaCurrent Opinion in Pediatrics, 23
-
T. Slotkin, Marisa Kreider, C. Tate, F. Seidler (2006)
Critical Prenatal and Postnatal Periods for Persistent Effects of Dexamethasone on Serotonergic and Dopaminergic SystemsNeuropsychopharmacology, 31
-
C. Crochemore, J. Lu, Y. Wu, Zsolt Liposits, N. Sousa, F. Holsboer, O. Almeida (2005)
Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activationMolecular Psychiatry, 10
-
B. Schmidt, P. Anderson, L. Doyle, D. Dewey, R. Grunau, E. Asztalos, P. Davis, W. Tin, D. Moddemann, A. Solimano, A. Ohlsson, K. Barrington, R. Roberts (2012)
Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.JAMA, 307 3
-
K. Rademaker, C. Uiterwaal, F. Groenendaal, M. Venema, F. Bel, F. Beek, Ingrid Haastert, D. Grobbee, L. Vries (2007)
Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.The Journal of pediatrics, 150 4
- Publisher
- American Medical Association
- Copyright
- Copyright 2017 American Medical Association. All Rights Reserved.
- ISSN
- 0098-7484
- eISSN
- 1538-3598
- DOI
- 10.1001/jama.2017.2692
- pmid
- 28384828
- Publisher site
- See Article on Publisher Site
Abstract
Key PointsQuestionIs early hydrocortisone treatment of extremely preterm infants associated with neurodevelopmental impairment at 2 years of age? FindingsIn an exploratory analysis of 379 infants enrolled in the PREMILOC (Early Low-Dose Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia in Extremely Preterm Infants) randomized clinical trial who survived to the age of 2 years, early low-dose hydrocortisone treatment was not associated with significantly worse neurodevelopmental impairment compared with placebo (hydrocortisone group: 73% without impairment, 20% with mild impairment, 7% with moderate to severe impairment; placebo group: 70% without impairment, 18% with mild impairment, and 11% with moderate to severe impairment). MeaningEarly low-dose hydrocortisone treatment in extremely preterm infants was not associated with a statistically significant difference in neurodevelopment at 2 years of age. Further randomized studies are needed to provide definitive assessment of the neurodevelopmental safety of hydrocortisone in extremely preterm infants.
Journal
JAMA – American Medical Association
Published: Apr 4, 2017